Showing results (211-220 of 255) with videos related to
Sort By:
Pageof 26
Peerj|May 3, 2013
Phenotypic characterization of patients with deletions in the 3'-flanking SHOX regionSarina G Kant, Sander J Broekman, Caroline C de Wit, et al.Endocrinology|March 17, 2016
A Human Variant of Glucose-Regulated Protein 94 That Inefficiently Supports IGF ProductionMichal Marzec, Colin P Hawkes, Davide Eletto, et al.The Journal of Clinical Endocrinology and Metabolism|June 22, 2006
Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutationSolrun Vidarsdottir, Marie J E Walenkamp, Alberto M Pereira, et al.Clinical Immunology (Orlando, Fla.)|June 19, 2013
Differentiating the roles of STAT5B and STAT5A in human CD4+ T cellsJennifer A Jenks, Scott Seki, Takahiro Kanai, et al.European Journal of Endocrinology|January 16, 2026
Diagnostic Yield of Genetic Testing in Children with Short Stature: a Systematic ReviewRenata C Scalco, Jan W Schoones, Despoina Galetaki, et al.Hormone Research in Paediatrics|March 2, 2016
Novel Leptin Receptor Mutations Identified in Two Girls with Severe Obesity Are Associated with Increased Bone Mineral DensitySabine E Hannema, Jan M Wit, Mieke E C A M Houdijk, et al.Journal of Voice : Official Journal of the Voice Foundation|October 26, 2010
The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndromeLeonie A Menke, Theo C J Sas, Sophie H L van Koningsbrugge, et al.Hormone Research in Paediatrics|July 2, 2024
IGF1 Haploinsufficiency: Phenotype and Response to Growth Hormone Treatment in 9 PatientsLauren D Punt, Daniëlle C M van der Kaay, Petra A van Setten, et al.The Journal of Clinical Endocrinology and Metabolism|March 20, 2008
Successful long-term growth hormone therapy in a girl with haploinsufficiency of the insulin-like growth factor-I receptor due to a terminal 15q26.2->qter deletion detected by multiplex ligation probe amplificationMarie J E Walenkamp, Sabine M P F de Muinck Keizer-Schrama, Marianne de Mos, et al.The Journal of Clinical Endocrinology and Metabolism|February 8, 2007
Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early pubertySandy A van Gool, Gerdine A Kamp, Hanneke Visser-van Balen, et al.Pageof 26